Cogent Biosciences Announces Positive Top-line Results of APEX Trial of Bezuclastinib in Patients with Advanced Systemic Mastocytosis 08 December 2025
Cogent Biosciences Presents Full SUMMIT Results of Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis  at the 67th Annual Meeting of the American Society of Hematology 06 December 2025
Cogent Biosciences Announces Participation in the Jefferies Global Healthcare Conference 14 November 2025
